Evidence map›Paper›PMID 41044388›Full record

ReviewArchives of toxicology2026

Estimating safe doses of perfluorooctane sulfonate (PFOS): an international collaboration.

Michael L Dourson, Laura C Green, Edmund A C Crouch, Harvey J Clewell, Thomas Colnot, Tony Cox, Wolfgang Dekant, Linda D Dell, James A Deyo, Bernard K Gadagbui and 19 more

Abstract readReview
In one paragraph

Review in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Michael L DoursonToxicology Excellence for Risk Assessment, Cincinnati, OH, USA. dourson@tera.org.ORCID 0000-0002-0735-9089
Laura C GreenGreen Toxicology LLC, Hull, MA, USA.
Edmund A C CrouchGreen Toxicology, Arlington, MA, USA.
Harvey J ClewellRamboll, Durham, NC, USA.
Thomas ColnotCiS Toxicology, Osorno, Chile.
Tony CoxCox Associates, Denver, CO, USA.
Wolfgang DekantUniversity of Würzburg (retired), Würzburg, Germany.
Linda D DellRamboll, Amherst, MA, USA.
James A DeyoEnvironmental Protection Authority, Wellington, New Zealand.
Bernard K GadagbuiToxicology Excellence for Risk Assessment, Cincinnati, OH, USA.
Helmut GreimTechnical University of Munich University (retired), Munich, Germany.
Mahesh Rachamalla GuptaUniversity of Saskatchewan, Saskatoon, Canada.
Tamara House-KnightGHD, North Little Rock, AR, USA.
Ashish JachakRHP Risk Management, Chicago, IL, USA.
Vijayavel Kannappan, Washington, DC, USA.
Travis R KlineGeosyntec Consultants, Farmington, MO, USA.
Therese ManningEnvironmental Risk Sciences Pty Ltd, Carlingford, Australia.
Ravi NaiduCRC CARE, Callaghan, Australia.
Paul NathanailLQM, Nottinghamshire, UK.
Chijioke OnyemaToxicology Excellence for Risk Assessment, Cincinnati, OH, USA.
Frank PagoneRHP Risk Management, Chicago, IL, USA.
Andrew PawliszTrihydro, Laramie, WY, USA.
Tiago Severo PeixeState University of Londrina, Londrina, Brazil.
Katie RichardsonSenversa, Melbourne, Australia.
Anurag SharmaNitte (Deemed to be University), Mangaluru, India.
James S SmithUS Department of Defense, Portsmouth, VA, USA.
Nitin VermaChitkara University, Himachal Pradesh, India.
Andrea WojtyniakGeosyntec Consultants International, Toronto, Canada.
Jackie WrightEnvironmental Risk Sciences Pty Ltd, Carlingford, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many government agencies and expert groups have estimated a safe dose (aka a "reference dose," [RfD]) for perfluorooctane sulfonate (PFOS). Notably, these agencies have derived safe doses that vary over at least 600-fold range. The range is larger still if one includes the U.S. Environmental Protection Agency (USEPA) current science-policy position under the Safe Drinking Water Act, which is that the only safe dose of PFOS is zero. This wide range in safe dose-estimates is surprising, since PFOS is a relatively well-studied, and ubiquitous, chemical. The Steering Committee of the Alliance for Risk Assessment (ARA) called for health-scientists interested in attempting to understand and, if possible, narrow this range of estimates. An advisory committee of eight scientists from four countries was selected from nominations received, and a subsequent invitation to scientists internationally led to the formation of three teams comprised of 24 scientists from nine countries. Each team independently reviewed toxicologic and epidemiologic data, and developed PFOS safe dose-estimates. All three teams concluded that currently available epidemiologic data could not form a reliable basis for PFOS safe dose-assessments. In contrast, results of bioassays of PFOS in laboratory monkeys and rats did provide usable bases from which serum-concentration-based "points of departure" were derived. After applying several, necessarily imprecise, uncertainty factors, the three groups derived PFOS safe dose-estimates that ranged, narrowly, from 20 to 100 nanograms (ng) of PFOS/kg body weight/day. In contrast, USEPA's current (United States Environmental Protection Agency (USEPA) (2024) Human health toxicity assessment for perfluorooctane sulfonic acid (PFOS) and Related Salts. EPA Document No. 815R24007.) estimate of the safe dose is 0.1 ng of PFOS/kg-day.

Indexed as

Alkanesulfonic AcidsEnvironmental ExposureEnvironmental PollutantsFluorocarbonsAnimalsDose-Response Relationship, DrugHumansInternational CooperationRatsRisk AssessmentUnited StatesUnited States Environmental Protection AgencyAlkanesulfonic AcidsEnvironmental PollutantsFluorocarbonsperfluorooctane sulfonic acidInternational differencesPFOSRegulatory policyRisk assessmentSafe dose

Identifiers

PMID41044388
PMCPMC12886202

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.